Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation

Ariful Haque Abir(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dirk Mielenz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Benjamin Frey(Friedrich-Alexander-Universität Erlangen-Nürnberg), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gerhard Krönke(Friedrich-Alexander-Universität Erlangen-Nürnberg), Heiko Bruns(Friedrich-Alexander-Universität Erlangen-Nürnberg), Udo S. Gaipl(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Life Science Alliance
October 22, 2025
10.26508/lsa.202503315
Cited by 2

Related Papers

Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
|Nature Immunology|2016|311
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
|Nature|2023|296
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
|Science Immunology|2022|280
Autophagy regulates TNFα-mediated joint destruction in experimental arthritis
|Annals of the Rheumatic Diseases|2012|265
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts
|Immunity|2021|245